Gastrointestinal anions

Gastrointestinal anions refer to a group of negatively charged ions and molecules within the digestive tract that are targeted by pharmacological sequestrants to prevent their systemic absorption. This category primarily includes inorganic phosphate, organic bile acids, and oxalate, which are associated with conditions such as hyperphosphatemia, hypercholesterolemia, and enteric hyperoxaluria (National Center for Biotechnology Information [NCBI], 2023). Drugs targeting these anions, such as sevelamer and cholestyramine, are non-absorbable polymers or salts that bind the anions in the intestinal lumen through ion exchange or physical adsorption (StatPearls, 2023). By sequestering these molecules, the drugs facilitate their excretion in the feces, thereby reducing their concentration in the blood or preventing localized damage. However, these agents are often non-specific and can lead to adverse effects, including constipation and the malabsorption of fat-soluble vitamins (A, D, E, and K) or other co-administered medications (Mayo Clinic, 2022). Clinical monitoring of serum electrolyte levels and lipid profiles is typically required to ensure therapeutic efficacy and safety (PubChem, 2024). Overall, while not a single molecular entity, these anions represent a significant class of therapeutic targets in renal and metabolic medicine.

Other names

Other gastrointestinal anionsIntestinal anionsLuminal anionsPhosphateBile acidsOxalate

Sequestration and binding of anions within the gastrointestinal lumen via ion exchange or adsorption to prevent systemic absorption and promote fecal excretion.